U2AF1 and myelodysplastic syndrome: In terms of peripheral blood examinations, some studies have shown that U2AF1 mutations (mainly U2AF1S34) are significantly associated with reduced hemoglobin level and platelet count, resulting in the higher rate of anemia and thrombocytopenia in U2AF1mut MDS patients [29,36,37,38,44,48].